A New Non-Statin Cholesterol Pill Is on the Market
A new FDA-approved cholesterol drug replaces injectable treatments with a daily pill—and experts say it delivers powerful results.
Similar Posts
Where Will Nvidia Stock Be in 2030?
Shares of Nvidia (NVDA +1.40%) have risen by an impressive 380% over the past three years, fueled by the artificial intelligence (AI)-driven demand for its data center chips. However, the stock has been in a rut lately, rising just 12% in 2026, as of this writing. The surprising thing to note here is that Nvidia…
XQQI: A Better NDX Income Structure I Won't Buy Yet
XQQI: A Better NDX Income Structure I Won't Buy Yet
SEC Crypto Rule Changes Are High on its 2026 Agenda
The US Securities and Exchange Commission (SEC) announced proposed rule changes that its chair said would “help clarify the regulatory framework for crypto assets and provide greater certainty to the market” as part of its annual agenda. In a Tuesday notice, SEC Chair Paul Atkins said that the agency’s 2026 agenda was intended to align…
Alternatives ETFs Punching Above Their Weight in 2026
Halfway through the year, the U.S. equity market performance is broadening. That said, market concentration remains incredibly high, while equity and bond correlations sit in positive territory — conditions that scream a call for diversification. Investors are heeding that call, many with alternatives ETFs. Key Takeaways: Alternative ETFs are seeing strong demand Structural diversification is…
ChatGPT Reveals How To Retire Without a 401(k)
meshaphoto / Getty Images Commitment to Our Readers GOBankingRates’ editorial team is committed to bringing you unbiased reviews and information. We use data-driven methodologies to evaluate financial products and services – our reviews and ratings are not influenced by advertisers. You can read more about our editorial guidelines and our products and services review methodology….
